DAFNA Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Sell |
|
|||||
|
2025
Q1 | $6.69M | Buy |
|
|||||
|
2024
Q4 | $7.17M | Buy |
|
|||||
|
2024
Q3 | $10.1M | Sell |
|
|||||
|
2024
Q2 | $13.5M | Sell |
|
|||||
|
2024
Q1 | $15.7M | Sell |
|
|||||
|
2023
Q4 | $16M | Buy |
|
|||||
|
2023
Q3 | $6.66M | Buy |
|
|||||
|
2023
Q2 | $9.44M | Buy |
|
|||||
|
2023
Q1 | $9.44M | Hold |
|
|||||
|
2022
Q4 | $11.4M | Buy |
|
|||||
|
2022
Q3 | $8.54M | Sell |
|
|||||
|
2022
Q2 | $7.14M | Sell |
|
|||||
|
2022
Q1 | $6.46M | Buy |
|
|||||
|
2021
Q4 | $6.49M | Buy |
|
|||||
|
2021
Q3 | $1.54M | Sell |
|
|||||
|
2021
Q2 | $2.54M | Buy |
|
|||||
|
2021
Q1 | $1.29M | Buy |
|
|||||
|
2020
Q4 | $222K | Sell |
|
|||||
|
2020
Q3 | $1.52M | Sell |
|
|||||
|
2020
Q2 | $5.33M | Buy |
|